Literature DB >> 17097811

Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.

Eva Fries1, Dirk H Hellhammer, Juliane Hellhammer.   

Abstract

Little is known about effects of commonly used anxiolytic drugs on psychologically evoked responses of two major stress systems, the hypothalamic-pituitary-adrenal (HPA) and the sympathetic-adrenal-medullary (SAM) axis. The purpose of the present study was to assess effects of the anxiolytic alprazolam on responses of the HPA and the SAM axes to a standardized psychosocial stress protocol, the Trier Social Stress Test (TSST). Forty-six healthy, non-smoking, non-medicated males, aged between 18 and 45 years, were invited once to the laboratory and received a single oral dose of 1mg alprazolam or placebo, respectively, 1h prior to the TSST. The secretion of ACTH, cortisol, epinephrine, norepinephrine as well as changes in heart rate, blood pressure, and psychological states (anxiety, wakefulness, good mood, calmness) in response to the TSST were measured. Subjects pre-treated with alprazolam showed a strongly blunted response of ACTH as well as total and free cortisol to the TSST. Whereas alprazolam-treated subjects displayed significantly lower systolic blood pressure immediately before the TSST, neither the secretion of epinephrine, norepinephrine nor changes of heart rate in response to the stress test differed from placebo-treated subjects. Regarding psychological parameters, alprazolam clearly decreased subjective ratings on the questionnaire scale "wakefulness" and increased ratings on the scale "good mood", whereas ratings on scales assessing "state anxiety" or "agitation" were not affected. In healthy subjects, we observed a dissociation of the effects of alprazolam on the endocrine and the autonomic response to psychosocial stress. The psychological responses seemed to be masked by sedative properties of alprazolam.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097811     DOI: 10.1016/j.psyneuen.2006.09.009

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

1.  The Trier Social Stress Test protocol for inducing psychological stress.

Authors:  Melissa A Birkett
Journal:  J Vis Exp       Date:  2011-10-19       Impact factor: 1.355

2.  Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.

Authors:  Elizabeth A Hoge; Eric Bui; Luana Marques; Christina A Metcalf; Laura K Morris; Donald J Robinaugh; John J Worthington; Mark H Pollack; Naomi M Simon
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

3.  The role of melatonin and cortisol circadian rhythms in the pathogenesis of infantile colic.

Authors:  Tolga İnce; Hakkı Akman; Dilek Çimrin; Adem Aydın
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

Review 4.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

5.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

Review 6.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

7.  Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats.

Authors:  Nicholas E Goeders; Glenn F Guerin
Journal:  Pharmacol Biochem Behav       Date:  2008-07-19       Impact factor: 3.533

8.  Effect of childhood emotional abuse and age on cortisol responsivity in adulthood.

Authors:  Linda L Carpenter; Audrey R Tyrka; Nicole S Ross; Lamya Khoury; George M Anderson; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2009-04-17       Impact factor: 13.382

9.  Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems.

Authors:  Susanne Becker; Petra Schweinhardt
Journal:  Pain Res Treat       Date:  2011-10-02

10.  Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Authors:  J M P Baas; N Mol; J L Kenemans; E P Prinssen; I Niklson; C Xia-Chen; F Broeyer; J van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2009-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.